SLC22A8
Organic anion transporter 3
Also known as: OAT3, S22A8_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TCC7
- Gene
- SLC22A8
- Ensembl
- ENSG00000149452
- Chromosome
- 11
- Canonical length
- 542 aa
- Protein class
- FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
This gene encodes a protein involved in the sodium-independent transport and excretion of organic anions, some of which are potentially toxic. The encoded protein is an integral membrane protein and appears to be localized to the basolateral membrane of the kidney. Multiple alternatively spliced transcript variants that encode different protein isoforms have been described for this gene. [provided by RefSeq, May 2010]
Canonical amino-acid sequenceUniProt
542 residues, UniProt reviewed canonical sequence.
>Q8TCC7|SLC22A8
1 MTFSEILDRV GSMGHFQFLH VAILGLPILN MANHNLLQIF TAATPVHHCR PPHNASTGPW
61 VLPMGPNGKP ERCLRFVHPP NASLPNDTQR AMEPCLDGWV YNSTKDSIVT EWDLVCNSNK
121 LKEMAQSIFM AGILIGGLVL GDLSDRFGRR PILTCSYLLL AASGSGAAFS PTFPIYMVFR
181 FLCGFGISGI TLSTVILNVE WVPTRMRAIM STALGYCYTF GQFILPGLAY AIPQWRWLQL
241 TVSIPFFVFF LSSWWTPESI RWLVLSGKSS KALKILRRVA VFNGKKEEGE RLSLEELKLN
301 LQKEISLAKA KYTASDLFRI PMLRRMTFCL SLAWFATGFA YYSLAMGVEE FGVNLYILQI
361 IFGGVDVPAK FITILSLSYL GRHTTQAAAL LLAGGAILAL TFVPLDLQTV RTVLAVFGKG
421 CLSSSFSCLF LYTSELYPTV IRQTGMGVSN LWTRVGSMVS PLVKITGEVQ PFIPNIIYGI
481 TALLGGSAAL FLPETLNQPL PETIEDLENW SLRAKKPKQE PEVEKASQRI PLQPHGPGLG
541 SSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC22A8 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 11
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 313 nTPM
Expression across tissuesHPA
Tissue
- kidney: 313 nTPM
- choroid plexus: 266 nTPM
- cerebral cortex: 1.5 nTPM
- cerebellum: 0.5 nTPM
- retina: 0.5 nTPM
- pituitary gland: 0.3 nTPM
Single-cell type
- retinal pigment epithelial cells: 465 nCPM
- proximal tubule cells: 148 nCPM
- choroid plexus epithelial cells: 148 nCPM
- retinal bipolar cells: 16 nCPM
- mast cells: 5 nCPM
- renal connecting tubule cells: 4.1 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 243 nTPM
- hippocampal formation: 7.7 nTPM
- cerebellum: 3.5 nTPM
- thalamus: 2.9 nTPM
- cerebral cortex: 0.9 nTPM
- midbrain: 0.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.15
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.97
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- monoatomic ion transport
- organic anion transport
- prostaglandin transport
- response to toxic substance
- transport across blood-brain barrier
Molecular functions
- organic anion transmembrane transporter activity
- prostaglandin transmembrane transporter activity
- solute:inorganic anion antiporter activity
- xenobiotic transmembrane transporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC22A8 as an antibody target. Whether an autoantibody or antibody against SLC22A8 could matter depends on whether native SLC22A8 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC22A8 is annotated at the cell surface, where native SLC22A8 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC22A8 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...